IL1B and nasopharyngeal carcinoma: Additionally, it was shown that nasopharyngeal carcinoma cells-derived IL-1β mediates anti-tumour effects on tumour-associated neutrophils, thus IL-1β blockade might prevent this beneficial effect of neutrophils72.